FDA publishes guidance for Inactive Ingredient Database
The FDA has released draft guidance for using the Inactive Ingredients Database to aid drug developers.
List view / Grid view
The FDA has released draft guidance for using the Inactive Ingredients Database to aid drug developers.
NICE has issued a recommendation for risankizumab to treat patients with severe plaque psoriasis.
A pharmaceutical manufacturing site in New Jersey receives FDA warning letter for failing to thoroughly investigate quality problems and data integrity issues.
The FDA and EMA have agreed to rely on each other’s assessment of pharmaceutical manufacturing sites to reduce duplicative work.
The NHS is set to launch a new payment method for antibiotic development to incentivise pharmaceutical companies.
Researchers have taken inspiration from jellyfish to create a small device that could be utilised for drug delivery.
A federal judge in the US has said that the Trump administration cannot require pharmaceutical companies to include drug prices in advertisements as it is beyond their authority.
PR001 has received Fast Track Designation from the regulatory body for the treatment of Parkinson’s disease.
The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to the exhibition grounds of Messe Basel, Switzerland. From 26 to 27 June 2019, a total of 379 exhibitors from 27 countries presented their innovative substances on a record net…
Two pharmaceutical companies have partnered to develop a slow-release drug to treat patients with HIV.
Pharmaceutical packaging in China has increased at a rate of 10 percent in recent years and is predicted to continue high growth.
MIT researchers have developed an algorithm which uses a new technique to predict missing data from clinical trial information.
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
The rise of diseases such as inflammatory bowel syndrome is projected to drive the global gastrointestinal drugs market in the upcoming years.
The EU has issued two guidance documents intended to advise the pharmaceutical industry and patients during medicinal shortages.